Structural studies on cell signalling via the LIF receptor and gp130
Structural studies on cell signalling via the LIF receptor and gp130
批准号:
nhmrc : 516730
负责人:
A/Pr James Murphy
金额:
$30.27万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-01 至 2010-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The cytokines play important roles in the immune system during blood cell development and inflammation, and in nerve growth, bone remodeling, reproduction and heart development. Cell responses are initiated by a cytokine bringing together on the cell surface a receptor complex made up of multiple molecules. This project will investigate the atomic structure of the cell surface macromolecular complex, and hence the underlying mechanism by which cytokine signals are initiated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unconventional mechanisms for activating the NLRP3 inflammasome
-
批准号:nhmrc : GNT1145788
-
项目类别:Project Grants
-
资助金额:$74.7万
-
财政年份:2018
-
负责人:A/Pr James Murphy
-
依托单位:
Unconventional mechanisms for activating the NLRP3 inflammasome
-
批准号:nhmrc : 1145788
-
项目类别:Project Grants
-
资助金额:$50.51万
-
财政年份:2018
-
负责人:A/Pr James Murphy
-
依托单位:
Assembly and function of two interacting oncogenic scaffolds
-
批准号:nhmrc : GNT1144149
-
项目类别:Project Grants
-
资助金额:$70.56万
-
财政年份:2018
-
负责人:A/Pr James Murphy
-
依托单位:
Assembly and function of two interacting oncogenic scaffolds
-
批准号:nhmrc : 1144149
-
项目类别:Project Grants
-
资助金额:$47.71万
-
财政年份:2018
-
负责人:A/Pr James Murphy
-
依托单位:
What is the molecular mechanism underlying cell death by necroptosis?
-
批准号:nhmrc : 1124735
-
项目类别:Project Grants
-
资助金额:$44.6万
-
财政年份:2017
-
负责人:A/Pr James Murphy
-
依托单位:
What is the molecular mechanism underlying cell death by necroptosis?
-
批准号:nhmrc : GNT1124735
-
项目类别:Project Grants
-
资助金额:$65.37万
-
财政年份:2017
-
负责人:A/Pr James Murphy
-
依托单位:
Targeting necroptosis signalling to counter stroke-induced brain injury
-
批准号:nhmrc : 1124737
-
项目类别:Project Grants
-
资助金额:$41.32万
-
财政年份:2017
-
负责人:A/Pr James Murphy
-
依托单位:
Mechanistic characterisation of the epigenetic modifier Smchd1
-
批准号:nhmrc : 1098290
-
项目类别:Project Grants
-
资助金额:$82.41万
-
财政年份:2016
-
负责人:A/Pr James Murphy
-
依托单位:
Mechanistic characterisation of the epigenetic modifier Smchd1
-
批准号:nhmrc : GNT1098290
-
项目类别:Project Grants
-
资助金额:$119.71万
-
财政年份:2016
-
负责人:A/Pr James Murphy
-
依托单位:
The emergence of "dead" enzymes as signal transducers and therapeutic targets
-
批准号:nhmrc : GNT1105754
-
项目类别:Career Development Fellowships
-
资助金额:$46.37万
-
财政年份:2016
-
负责人:A/Pr James Murphy
-
依托单位:
The emergence of "dead" enzymes as signal transducers and therapeutic targets
-
批准号:nhmrc : 1105754
-
项目类别:Career Development Fellowships
-
资助金额:$31.9万
-
财政年份:2016
-
负责人:A/Pr James Murphy
-
依托单位:
MLKL-regulated necroptosis pathways in disease
-
批准号:nhmrc : 1057905
-
项目类别:Project Grants
-
资助金额:$40.72万
-
财政年份:2014
-
负责人:A/Pr James Murphy
-
依托单位:
Genomic analysis of the novel epigenetic modifier Smchd1 as a tumour suppressor
-
批准号:nhmrc : 1045936
-
项目类别:Project Grants
-
资助金额:$41.28万
-
财政年份:2013
-
负责人:A/Pr James Murphy
-
依托单位:
Cytokine-driven allergic inflammation: characterization of two isoform-specific modes of IL-3 receptor activation and investigation of new receptor-associated signalling partners.
-
批准号:nhmrc : 1033368
-
项目类别:Project Grants
-
资助金额:$41.39万
-
财政年份:2012
-
负责人:A/Pr James Murphy
-
依托单位:
Understanding SOCS3 inhibition of JAK activity in myeloproliferative disorders
-
批准号:nhmrc : 1011804
-
项目类别:Project Grants
-
资助金额:$35.0万
-
财政年份:2011
-
负责人:A/Pr James Murphy
-
依托单位:
The characterization of a novel pseudokinase regulator of platelet formation
-
批准号:nhmrc : 637342
-
项目类别:NHMRC Project Grants
-
资助金额:$24.87万
-
财政年份:2010
-
负责人:A/Pr James Murphy
-
依托单位:
Structure-function analysis of mammalian PAR-6 polarity complexes
-
批准号:nhmrc : 305546
-
项目类别:Early Career Fellowships
-
资助金额:$24.23万
-
财政年份:2004
-
负责人:A/Pr James Murphy
-
依托单位:
国内基金
海外基金
脂滴聚集型小胶质细胞介导的髓鞘病变促进小鼠抑郁样行为及其机制研究
-
批准号:82371528
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李媛
-
依托单位:
星形胶质细胞介导的髓鞘吞噬参与慢性脑低灌注白质损伤的机制研究
-
批准号:82371307
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:汤耀辉
-
依托单位: